¼¼°èÀÇ ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå : °Ë»ç À¯Çüº°, ±â¼úº°, Á¦Ç° À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)
Cellular Health Screening Test Market, By Test Type, By Technology, By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1358204
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 352 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,452,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,370,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,741,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× ½ÃÀå ±Ô¸ð´Â 2022³â 31¾ï 470¸¸ ´Þ·¯¿´À¸¸ç, 2023³âºÎÅÍ 2030³â±îÁö CAGR 9.83%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå - ½ÃÀå ¿ªÇÐ :

¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå-¼¼ºÐÈ­ ºÐ¼® :

¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå-Áö¸®Àû ÅëÂû :

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â ÃÖ´ë ½ÃÀåÀÔ´Ï´Ù. ÀÌ ¼ºÀåÀÇ ¹è°æ¿¡´Â ¿¹¹æ Áø´Ü °Ë»çÀÇ Ã¤Åà Áõ°¡, ¼¼Æ÷ ³ëÈ­¿¡ °üÇÑ Á¶»ç Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç°¡ ÀÖ½À´Ï´Ù. À¯·´ ½ÃÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´×¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, °Ç°­ °ü¸® ÁöÃâ Áõ°¡·Î 2À§ ½ÃÀåÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¾Æ½Ã¾Æ ÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È ¼¼Æ÷ °Ç°­ °Ë»ç °Ë»ç ½ÃÀå¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ½ÃÀåÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¼ºÀåÀº °Ç°­ °ü¸® ÀÎÇÁ¶ó °³¼±, À¯¸®ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê ¹× ȯÀÚ ¼ö¿µÀåÀÇ È®´ë·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.

¼¼Æ÷ °Ç°­ °Ë»ç °Ë»ç ½ÃÀå-°æÀï ±¸µµ :

Á¦Á¶»ç °¢ ȸ»ç´Â °³ÀÎÀÇ ¶óÀÌÇÁ ½ºÅ¸ÀÏ, À¯ÀüÀû üÁú ¹× ȯ°æ ¿äÀο¡ µû¶ó °³º°È­ µÈ ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»çÀÇ °³¹ß¿¡ Áö¼ÓÀûÀ¸·Î ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü °Ë»ç´Â ¸ÂÃãÇü °³ÀÔ ¹× ±ÇÀåÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ÀüÅë ±â¾÷°ú ½ÅÈï ±â¾÷ÀÌ È¥ÇյǾî ÀÖ½À´Ï´Ù. ½ÅÈï ±â¾÷Àº °Ë»ç¿¡ Çõ½Å°ú Âü½ÅÇÑ Á¢±Ù¹ýÀ» Á¦°øÇÏÁö¸¸, ±âÁ¸ ±â¾÷Àº º¸Åë ¾öû³­ À¯ÇüÀÇ °Ë»ç¿Í ¸¶ÄÏÇ÷¹À̽º¿¡¼­ °­·ÂÇÑ Á¸Àç°¨À» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷Àº Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÃÊÁ¡À» ¸ÂÃß°í ¼¼Æ÷ ½ºÅ©¸®´×À» ½ÃÀå È®´ë ¹× Ç¥ÁØ Ä¡·á ·çƾ¿¡ ³õ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 8¿ù ´Ù°¢Àû ÀÇ·á °úÇÐ ±â¼ú ±â¾÷ÀÎ ProPhase Labs, Inc.´Â °³ÀÎ °Ô³ð ±â¾÷ÀÎ Nebula GenomicsÀÇ Àμö¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ´ç»ç´Â ³×ºæ¶óÀÇ Àüü °Ô³ð ½ÃÄö½Ì ¼­ºñ½º¸¦ ÇÁ·ÎÆäÀÌÁîÀÇ CLIA ÀÎÁõ ºÐÀÚ °Ë»ç ½ÇÇè½Ç¿¡¼­ ÀÌ¹Ì Á¦°øµÈ °ß°íÇÑ ÀÓ»ó Áø´Ü °Ë»ç ¼­ºñ½º¿Í ÅëÇÕÇÒ ¿¹Á¤ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç-ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç-»ê¾÷ ¿¬±¸ Á¶»ç

Á¦5Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå : COVID-19 ¿µÇ⠺м®

Á¦6Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå »óȲ

Á¦7Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå-°Ë»ç À¯Çüº°

Á¦8Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå-±â¼úº°

Á¦9Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå-Á¦Ç° À¯Çüº°

Á¦10Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå-ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå ¼¼Æ÷ °Ç°­ ½ºÅ©¸®´× °Ë»ç ½ÃÀå-Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼®-ÈÞ´ëÆù °Ç°­ ½ºÅ©¸®´× °Ë»ç »ê¾÷

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LYJ
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Cellular health screening test market size was valued at USD 3,104.7 Million in 2022, expanding at a CAGR of 9.83% from 2023 to 2030.

Cellular health screening has become important as it affects an individual health quality. Bio-energy is generated by healthy cells, which eventually leads to normal health. Additionally, cellular health screening tests are intended to offer insights into an individual's general health at a cellular level, assessing several parameters including inflammation, oxidative stress, cellular aging, and mitochondrial function. These tests are becoming popular owing to the growing emphasis on preventive personalized and healthcare medicine.

Cellular Health Screening Test Market - Market Dynamics:

Cellular Health Screening Test Market - Key Insights:

Cellular Health Screening Test Market- Segmentation Analysis:

Cellular Health Screening Test Market - Geographical Insights:

North America is accounted to be the largest market during the forecast period. The growth is attributed to the increasing adoption of preventive diagnostic tests, increasing research on cellular aging, and the presence of key players. The European market is likely to be the second-largest market owing to the increasing prevalence of chronic diseases, growing awareness regarding cellular health screening, and increasing healthcare expenditure. The Asia Pacific is projected to be the fastest-growing market for cellular health screening test market over the forecast period. The growth is attributed to the improving healthcare infrastructure, favorable government initiatives, and expanding patient pool.

Cellular Health Screening Test Market- Competitive Landscape:

Manufacturers are constantly focusing on developing personalized cellular health screening tests based on an individual's lifestyle, genetic makeup, and environmental factors. Customized testing enables tailored interventions and recommendations. The market is populated with a combination of well-established players and new startups. Startups bring innovation and fresh approaches to testing, whereas established companies typically possess a vast range of tests and a strong presence in the marketplace. Moreover, key players are focusing on strategic partnerships to position cellular screening to expand market reach and in routine standard of care. For instance, in August 2021, ProPhase Labs, Inc. a diversified medical science and Technology Company announced the acquisition of Nebula Genomics, a privately-owned personal genomics company. The Company intends to integrate Nebula's whole genome sequencing services with the robust clinical diagnostic testing services already provided at ProPhase's CLIA-certified molecular testing laboratories.

Recent Developments:

For instance, in January 2021, Decibel Therapeutics, announced a partnership with Invitae, to launch AmplifyTM, a no-charge genetic testing program to screen for the genetic cause of congenital hearing loss in children diagnosed with auditory neuropathy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELLULAR HEALTH SCREENING TEST MARKET KEY PLAYERS

GLOBAL CELLULAR HEALTH SCREENING TEST MARKET, BY TEST TYPE

GLOBAL CELLULAR HEALTH SCREENING TEST MARKET, BY TECHNOLOGY

GLOBAL CELLULAR HEALTH SCREENING TEST MARKET, BY PRODUCT TYPE

GLOBAL CELLULAR HEALTH SCREENING TEST MARKET, BY END USER

GLOBAL CELLULAR HEALTH SCREENING TEST MARKET, BY REGION

Table of Contents

1. Cellular Health Screening Test Market Overview

2. Executive Summary

3. Cellular Health Screening Test Key Market Trends

4. Cellular Health Screening Test Industry Study

5. Cellular Health Screening Test Market: COVID-19 Impact Analysis

6. Cellular Health Screening Test Market Landscape

7. Cellular Health Screening Test Market - By Test Type

8. Cellular Health Screening Test Market - By Technology

9. Cellular Health Screening Test Market - By Product Type

10. Cellular Health Screening Test Market - By End User

11. Cellular Health Screening Test Market- By Geography

12. Key Vendor Analysis- Cellular Health Screening Test Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â